In Brief: FSMA deadlines, adulteration bill, pharma supply chain pilot
This article was originally published in The Tan Sheet
FSMA deadlines set in consent decree; supplement adulteration legislation introduced; Maximus Niterider has GMP problems; modified risk claim on tobacco committee agenda; and more In Brief.
You may also be interested in...
FDA’s delays in implementing the Food Safety Modernization Act violated FSMA and the Administrative Procedures Act, a federal court finds in an April 22 order. The agency must meet with plaintiff Center for Food Safety to agree on new implementation deadlines by May 20.
Keeping Track: StrataGraft Continues US FDA’s Biologic Center Approvals Streak; Another CRL For Avenue’s Tramadol IV
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Sens. Durbin and Grassley hope report will help revive their flagging legislation that would require Rx ads to include list prices Senators claim that the Government Accountability Office concludes that direct-to-consumer spots for prescription drugs drives ‘drastic’ increases in Medicare costs.